These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
329 related articles for article (PubMed ID: 24551295)
1. Expression characteristics of CDC20 in gastric cancer and its correlation with poor prognosis. Ding ZY; Wu HR; Zhang JM; Huang GR; Ji DD Int J Clin Exp Pathol; 2014; 7(2):722-7. PubMed ID: 24551295 [TBL] [Abstract][Full Text] [Related]
2. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer. Sato Y; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Yanaka Y; Kobayashi K; Higuchi K; Kojima K; Kawano T J Clin Pathol; 2015 Oct; 68(10):795-801. PubMed ID: 26043748 [TBL] [Abstract][Full Text] [Related]
3. HOX transcript antisense intergenic RNA represses E-cadherin expression by binding to EZH2 in gastric cancer. Chen WM; Chen WD; Jiang XM; Jia XF; Wang HM; Zhang QJ; Shu YQ; Zhao HB World J Gastroenterol; 2017 Sep; 23(33):6100-6110. PubMed ID: 28970725 [TBL] [Abstract][Full Text] [Related]
4. Overexpression of kallikrein gene 10 is a biomarker for predicting poor prognosis in gastric cancer. Jiao X; Lu HJ; Zhai MM; Tan ZJ; Zhi HN; Liu XM; Liu CH; Zhang DP World J Gastroenterol; 2013 Dec; 19(48):9425-31. PubMed ID: 24409072 [TBL] [Abstract][Full Text] [Related]
5. Expression of pyruvate dehydrogenase is an independent prognostic marker in gastric cancer. Sun XR; Sun Z; Zhu Z; Guan HX; Li CY; Zhang JY; Zhang YN; Zhou H; Zhang HJ; Xu HM; Sun MJ World J Gastroenterol; 2015 May; 21(17):5336-44. PubMed ID: 25954108 [TBL] [Abstract][Full Text] [Related]
6. Increased expression of FOXQ1 is a prognostic marker for patients with gastric cancer. Liang SH; Yan XZ; Wang BL; Jin HF; Yao LP; Li YN; Chen M; Nie YZ; Wang X; Guo XG; Wu KC; Ding J; Fan DM Tumour Biol; 2013 Oct; 34(5):2605-9. PubMed ID: 23609035 [TBL] [Abstract][Full Text] [Related]
7. Overexpression of ILK1 in breast cancer associates with poor prognosis. Yang HJ; Zheng YB; Ji T; Ding XF; Zhu C; Yu XF; Ling ZQ Tumour Biol; 2013 Dec; 34(6):3933-8. PubMed ID: 23832543 [TBL] [Abstract][Full Text] [Related]
8. Myofibrillogenesis regulator-1 overexpression is associated with poor prognosis of gastric cancer patients. Guo J; Dong B; Ji JF; Wu AW World J Gastroenterol; 2012 Oct; 18(38):5434-41. PubMed ID: 23082061 [TBL] [Abstract][Full Text] [Related]
9. Correlations of lysyl oxidase with MMP2/MMP9 expression and its prognostic value in non-small cell lung cancer. Liu J; Ping W; Zu Y; Sun W Int J Clin Exp Pathol; 2014; 7(9):6040-7. PubMed ID: 25337249 [TBL] [Abstract][Full Text] [Related]
10. Expressions and clinical significances of CD133 protein and CD133 mRNA in primary lesion of gastric adenocacinoma. Yu JW; Zhang P; Wu JG; Wu SH; Li XQ; Wang ST; Lu RQ; Ni XC; Jiang BJ J Exp Clin Cancer Res; 2010 Nov; 29(1):141. PubMed ID: 21054902 [TBL] [Abstract][Full Text] [Related]
11. Decreased expression of histone deacetylase 10 predicts poor prognosis of gastric cancer patients. Jin Z; Jiang W; Jiao F; Guo Z; Hu H; Wang L; Wang L Int J Clin Exp Pathol; 2014; 7(9):5872-9. PubMed ID: 25337229 [TBL] [Abstract][Full Text] [Related]
12. Correlation of human epidermal growth factor receptor 2 expression with clinicopathological characteristics and prognosis in gastric cancer. He C; Bian XY; Ni XZ; Shen DP; Shen YY; Liu H; Shen ZY; Liu Q World J Gastroenterol; 2013; 19(14):2171-8. PubMed ID: 23599643 [TBL] [Abstract][Full Text] [Related]
13. NEDD9 overexpression correlates with the progression and prognosis in gastric carcinoma. Shi R; Wang L; Wang T; Xu J; Wang F; Xu M Med Oncol; 2014 Mar; 31(3):852. PubMed ID: 24469954 [TBL] [Abstract][Full Text] [Related]
14. Clinicopathological significance of orphan nuclear receptor Nurr1 expression in gastric cancer. Guo J; Zu G; Zhou T; Xing J; Wang Z Clin Transl Oncol; 2015 Oct; 17(10):788-94. PubMed ID: 26022133 [TBL] [Abstract][Full Text] [Related]
15. Reduced stratifin expression can serve as an independent prognostic factor for poor survival in patients with esophageal squamous cell carcinoma. Ren HZ; Pan GQ; Wang JS; Wen JF; Wang KS; Luo GQ; Shan XZ Dig Dis Sci; 2010 Sep; 55(9):2552-60. PubMed ID: 20108042 [TBL] [Abstract][Full Text] [Related]
16. H19 serves as a diagnostic biomarker and up-regulation of H19 expression contributes to poor prognosis in patients with gastric cancer. Chen JS; Wang YF; Zhang XQ; Lv JM; Li Y; Liu XX; Xu TP Neoplasma; 2016; 63(2):223-30. PubMed ID: 26774144 [TBL] [Abstract][Full Text] [Related]
17. Overexpression of TNFAIP8 is associated with tumor aggressiveness and poor prognosis in patients with invasive ductal breast carcinoma. Xiao M; Xu Q; Lou C; Qin Y; Ning X; Liu T; Zhao X; Jia S; Huang Y Hum Pathol; 2017 Apr; 62():40-49. PubMed ID: 28087477 [TBL] [Abstract][Full Text] [Related]
18. Reduced group IVA phospholipase A2 expression is associated with unfavorable outcome for patients with gastric cancer. Zhang X; Wu Q; Gan L; Yu GZ; Wang R; Wang ZS; Wang JJ; Wang X Med Oncol; 2013 Mar; 30(1):454. PubMed ID: 23307260 [TBL] [Abstract][Full Text] [Related]
19. Diversity of clinical implication of B-cell translocation gene 1 expression by histopathologic and anatomic subtypes of gastric cancer. Kanda M; Oya H; Nomoto S; Takami H; Shimizu D; Hashimoto R; Sueoka S; Kobayashi D; Tanaka C; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y Dig Dis Sci; 2015 May; 60(5):1256-64. PubMed ID: 25487193 [TBL] [Abstract][Full Text] [Related]
20. Increased expression of pleiotrophin is a prognostic marker for patients with gastric cancer. Hu H; Li C; Cai S; Zhu C; Tian Y; Zheng J; Hu J; Chen C; Liu W Hepatogastroenterology; 2014; 61(133):1478-82. PubMed ID: 25436328 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]